Patients report less back and knee pain as weight drops, but doctors warn fast weight loss can weaken bones, with older users most at risk.
Recap by typeshit. Post by @qz on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
The scale went up roughly 2.5 pounds since the last check-in, but the poster says life on tirzepatide is going well overall.
ScienceAlert reports the rate among people who never took the drugs was 9%, a gap researchers say is worth investigating further.
Loading…